BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8016663)

  • 1. Pathophysiology of sodium retention and ascites formation in cirrhosis: role of atrial natriuretic factor.
    Wong F; Blendis L
    Semin Liver Dis; 1994 Feb; 14(1):59-70. PubMed ID: 8016663
    [No Abstract]   [Full Text] [Related]  

  • 2. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of atrial natriuretic factor in sodium and water retention in patients with schistosomal hepatic fibrosis.
    Habib YA; Kira LH; el-Sherbini HA; Asser LA; el-Shamy EA; Hatem YA
    J Trop Med Hyg; 1991 Aug; 94(4):272-6. PubMed ID: 1831860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deranged sodium homeostasis in cirrhosis.
    Epstein M
    Gastroenterology; 1979 Mar; 76(3):622-35. PubMed ID: 428715
    [No Abstract]   [Full Text] [Related]  

  • 5. Atrial natriuretic peptide: renal effects in cirrhosis of the liver.
    Levy M
    Semin Nephrol; 1997 Nov; 17(6):520-9. PubMed ID: 9353863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kidney in chronic liver disease: circulatory abnormalities, renal sodium handling and role of natriuretic peptides.
    Valdivieso A
    Biol Res; 1998; 31(3):291-304. PubMed ID: 9830517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperresponsiveness to water immersion in sodium retaining cirrhotics: the role of atrial natriuretic factor.
    Campbell PJ; Leung WM; Logan AG; Debowski TE; Blendis LM; Skorecki KL
    Clin Invest Med; 1988 Dec; 11(6):392-5. PubMed ID: 2976331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of ascites and renal salt retention in cirrhosis.
    Palmer BF
    J Investig Med; 1999 May; 47(5):183-202. PubMed ID: 10361377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide in hepatic cirrhosis: relation to stage of disease, sympathoadrenal system and renin-aldosterone axis.
    Burghardt W; Wernze H; Diehl KL
    Klin Wochenschr; 1986; 64 Suppl 6():103-7. PubMed ID: 2948055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
    Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW
    Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of immunoreactive atrial natriuretic peptide in hospitalized cirrhotic and noncirrhotic patients: evidence for a role of deficient atrial natriuretic peptide in pathogenesis of cirrhotic ascites.
    Bonkovsky HL; Hartle DK; Mellen BG; Kutner M; Galambos JT
    Am J Gastroenterol; 1988 May; 83(5):531-5. PubMed ID: 2966574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Human atrial natriuretic factor (hANF) in liver cirrhosis].
    Pidlich J; Müller C; Hartter E; Renner F; Klepetko W; Miholic J; Woloszczuk W
    Acta Med Austriaca; 1987; 14(5):125-9. PubMed ID: 2964160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal sodium handling in cirrhosis with ascites: mechanisms of impaired natriuretic response to reclining.
    Bernardi M; Trevisani F; Fornalè L; Di Marco C; Gasbarrini A; Baraldini M; Ligabue A; Gasbarrini G
    J Hepatol; 1994 Dec; 21(6):1116-22. PubMed ID: 7699237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of peritoneovenous shunting in unravelling the pathogenesis of ascites in cirrhosis.
    Blendis LM
    Isr J Med Sci; 1986 Feb; 22(2):78-80. PubMed ID: 3512475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disorders of regulation of the stability of the intravascular fluid volume in patients with liver cirrhosis].
    Gapon LI
    Ter Arkh; 1987; 59(2):100-4. PubMed ID: 3576460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atrial natriuretic paptide in liver cirrhosis].
    Krstić M; Abramović D; Tomić D; Jesić R; Janković G; Marisavljević D; Ivanović B
    Srp Arh Celok Lek; 1994; 122(3-4):86-8. PubMed ID: 17972817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic factor and renin-aldosterone in volume regulation of patients with cirrhosis.
    Gerbes AL; Wernze H; Arendt RM; Riedel A; Sauerbruch T; Paumgartner G
    Hepatology; 1989 Mar; 9(3):417-22. PubMed ID: 2522081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atrial natriuretic factor. Initial results of possible significance in liver cirrhosis].
    Gerbes AL; Arendt RM; Sauerbruch T; Paumgartner G
    Leber Magen Darm; 1987 Dec; 17(6):393-404. PubMed ID: 2963183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of atrial natriuretic factor on renal excretion of sodium in patients with liver cirrhosis].
    Moreau R; Lebrec D
    Gastroenterol Clin Biol; 1994; 18(6-7):568-73. PubMed ID: 7875416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.